We are live on
!
Find out more
ST
SAL Trading Portfolio holdings
AUM
$57M
1-Year Est. Return
33.89%
This Fund
S&P 500
This Quarter
Est. Return
+5.07%
1 Year Est. Return
+33.89%
3 Year Est. Return
+18.85%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.2M
AUM Growth
-$29.5M
(-34%)
Cap. Flow
-$32.1M
Cap. Flow
% of AUM
-55.2%
Top 10 Holdings %
Top 10 Hldgs %
99.31%
Holding
18
New
4
Increased
1
Reduced
5
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$3.67M |
| 2 |
BP
BP
|
+$881K |
| 3 |
CMBT
CMB.TECH NV
CMBT
|
+$192K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
British American Tobacco
BTI
|
+$1.25M |
| 2 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
+$486K |
| 3 |
argenx
ARGX
|
+$115K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.99% |
| 2 | Energy | 1.78% |
| 3 | Consumer Staples | 1.59% |
| 4 | Consumer Discretionary | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $44.6M | 76.6% |
81,899
| – | – |
|
|
2
AstraZeneca
AZN
$269B
| $6.14M | 10.55% |
39,351
+24,400
| +163% | +$3.67M |
|
3
PUT
BHP
BHP
$214B
| $1.27M | 2.18% |
+22,200
| New | +$1.29M |
|
|
4
British American Tobacco
BTI
$135B
| $924K | 1.59% |
29,869
-41,031
| -58% | -$1.25M |
|
|
5
PUT
argenx
ARGX
$55.1B
| $903K | 1.55% |
2,100
-18,100
| -90% | -$6.93M |
|
|
6
CALL
BHP
BHP
$214B
| $862K | 1.48% |
+15,100
| New | +$877K |
|
|
7
BP
BP
$111B
| $848K | 1.46% |
+23,500
| New | +$881K |
|
|
8
argenx
ARGX
$55.1B
| $838K | 1.44% |
1,949
-300
| -13% | -$115K |
|
9
CALL
Rio Tinto
RIO
$153B
| $824K | 1.42% |
12,500
-151,500
| -92% | -$10.3M |
|
10
Ferrari
RACE
$68.4B
| $613K | 1.05% |
1,500
| – | – |
|
|
11
CALL
argenx
ARGX
$55.1B
| $215K | 0.37% |
500
-11,600
| -96% | -$4.44M |
|
|
CMBT
12
CMB.TECH NV
CMBT
$4.56B
| $187K | 0.32% |
+11,300
| New | +$192K |
|
13
CALL
ASML
ASML
$610B
| – | – |
-5,400
| Closed | -$5.24M |
|
|
14
CALL
AstraZeneca
AZN
$269B
| – | – |
-6,250
| Closed | -$847K |
|
|
15
PUT
AstraZeneca
AZN
$269B
| – | – |
-12,200
| Closed | -$1.65M |
|
|
16
PUT
Rio Tinto
RIO
$153B
| – | – |
-119,200
| Closed | -$7.6M |
|
|
CMBT
17
CALL
CMB.TECH NV
CMBT
$4.56B
| – | – |
-10,200
| Closed | -$170K |
|
|
MOR
18
DELISTED
MorphoSys AG American Depositary Shares
MOR
| – | – |
-26,800
| Closed | -$486K |
|
Similar funds
ARC
AGFIA
SVG
TM
LOF
BCM
MAM
LAMC
SAL Trading's Q2 2024 Portfolio in Review
As of Q2 2024, SAL Trading held 18 positions worth $58.2M, down 34% from $87.7M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
SAL Trading withdrew a net $32.1M in Q2 2024, closing 6 positions and reducing 5 holdings. Its most notable exit was MorphoSys AG American Depositary Shares, an estimated $486K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 3.9% a quarter earlier, followed by Energy and Consumer Staples.
Against the trend, SAL Trading opened a new position in BP worth $848K.
- SAL Trading's largest Q2 2024 buy was BP: 23,500 shares worth $848K.
- SAL Trading added most to AstraZeneca in Q2 2024, an estimated $3.67M increase.
- SAL Trading's biggest Q2 2024 reduction was British American Tobacco, cutting an estimated $1.25M.
- SAL Trading fully exited MorphoSys AG American Depositary Shares in Q2 2024, selling an estimated $486K.
- SAL Trading's ten largest holdings make up 99% of its $58.2M portfolio in Q2 2024.
- SAL Trading opened 4 new positions and closed 6 in Q2 2024.
- SAL Trading's portfolio value fell 34% quarter-over-quarter to $58.2M.
Based on SAL Trading's 13F filing for Q2 2024, filed 15 Aug 2024.